In Massachusetts, GenePeeks, Inc. has a new President and Chief Commercial Officer, Matt Posard, who comes with over 25 years of experience at a variety of genomic and life sciences companies including Illumina, Inc., Trovagene, Inc. and Alere, Inc. His role at GenePeeks will be to head up commercialization of their computational genomics products and services. Their patented Virtual Progeny Analytics product takes the genetic makeup of two parents and computationally predicts what diseases or health issues their child will be at risk for, genetically speaking, before they even conceive a baby. Many parents want to know the risks before they conceive, especially for serious diseases, so they can be more prepared for the possibilities.
Latest article
Fin-ished, for now: Aqua Cultured Foods shutters as funding dries up
In Chicago, a fermentation startup converting cellulose into seafood alternatives has wound down operations after failing to raise funds necessary to reach commercialization.
Established...
Mercedes unveils vegan-interior SUV at CES
In Nevada, Mercedes-Benz has showcased a new, vegan-interior GLC electronic SUV at the recent CES technology trade show in Las Vegas.
Vegan materials were...
Futerro files permits for French PLA site
In France, biobased chemicals maker Futerro has requested the relevant permits for its planned lactic acid and polylactic acid plant in France.
The plant, which...